Leah Lawrence

1 month ago | oncologynewscentral.com | Emily Bader |Youssef Rddad |Marcia Frellick |Leah Lawrence

PD-L1 inhibitors have dramatically changed outcomes for some cancers by flipping the off switch on regulatory proteins that help cancer cells evade the immune system. However, these immune checkpoint inhibitors (CPIs) have their share of adverse effects, including increased risk for autoimmune conditions such as rheumatoid arthritis.

1 month ago | oncologynewscentral.com | Leah Lawrence |Neil Osterweil |Youssef Rddad

Although the incidence of cervical cancer plateaued or decreased among women living in urban counties of the United States, women in rural counties had increased incidence in recent years, according to data recently published in JAMA Network Open. Notably, the gap between cervical cancer mortality in rural counties and rates in urban counties has also widened in recent years, the study showed.

May 7, 2024 | oncologynewscentral.com | Leah Lawrence |Youssef Rddad |Rabiya Tuma |Ursula Matulonis